genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2024

Viral vaccine

GeoVax Advances COVID-19 Vaccine with Up to $45M from BARDA
GEN Edge

GeoVax Advances COVID-19 Vaccine with Up to $45M from BARDA

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga
GEN Edge

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga

Entos Expands In-House Manufacturing with GMP Facility
Bioprocessing

Entos Expands In-House Manufacturing with GMP Facility

HIV Vaccine Triggered Elusive Broadly Neutralizing HIV Antibodies, Trial Shows
Infectious Diseases

HIV Vaccine Triggered Elusive Broadly Neutralizing HIV Antibodies, Trial Shows

StockWatch: MacroGenics Shares Crater after Trial Deaths
Drug Discovery

StockWatch: MacroGenics Shares Crater after Trial Deaths

Vaccine Adjuvant from Tree Bark Has Been Produced by Engineered Yeast
Bioprocessing

Vaccine Adjuvant from Tree Bark Has Been Produced by Engineered Yeast

Universal Flu Vaccine May No Longer Be a Long Shot
Drug Discovery

Universal Flu Vaccine May No Longer Be a Long Shot

Vaccine Developers Leverage mRNA and Other Powerful  Technologies
Infectious Diseases

Vaccine Developers Leverage mRNA and Other Powerful Technologies

Global Approach to Standardized Viral Vector Manufacturing
Bioprocessing

Global Approach to Standardized Viral Vector Manufacturing

Universal Vaccine Strategy Boosts Body’s RNAi Response to Viruses
Drug Discovery

Universal Vaccine Strategy Boosts Body’s RNAi Response to Viruses

123...66Page 1 of 66

Read the Digital Edition

June 2024 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up